US2021109940A1
|
|
System and method for confidentiality-preserving rank-ordered search
|
US2021077195A1
|
|
Confidence-based robotically-assisted surgery system
|
US2021119417A1
|
|
High power, narrow linewidth semiconductor laser system and method of fabrication
|
WO2021076875A1
|
|
A novel active ingredient in sunscreen compositions
|
WO2021072385A1
|
|
Compositions and methods for delivering nucleic acids to cells
|
US2021010962A1
|
|
In situ, real-time in-line detection of filling errors in pharmaceutical product manufacturing using water proton nmr
|
WO2021041469A1
|
|
Method and apparatus for individualized administration of medicaments for enhanced safe delivery within a therapeutic range
|
WO2021035162A1
|
|
Ion-conducting structures, devices including ion-conducting structures, and methods for use and fabrication thereof
|
WO2021030571A1
|
|
Methods of treating psychological and brain disorders
|
US2021032411A1
|
|
Synthetic, mucus-like hydrogel and method of preparation, and system and method for performing microrheology on hydrogels and other complex fluids
|
WO2021007329A2
|
|
Treatment of pulmonary fibrosis using inhibitors of neu1 sialidase
|
US2020330529A1
|
|
Microbiome-based informed method to formulate live biotherapeutics
|
US2020401702A1
|
|
Method and System for Reducing False Positives in Static Source Code Analysis Reports Using Machine Learning and Classification Techniques
|
WO2020252435A1
|
|
Systems and methods for high temperature synthesis of single atom dispersions and multi-atom dispersions
|
WO2020247942A1
|
|
Adjuvants for immunogenic compositions and methods of use thereof
|
WO2020247860A1
|
|
Broad spectrum antiviral compounds targeting the ski complex
|
WO2020247500A1
|
|
Humanized tetra-specific octavalent antibody against clostridium difficile toxin a and b
|
US2020345495A1
|
|
Valve translocation device and method for the treatment of functional valve regurgitation
|
US2020379427A1
|
|
Automatic vision guided intelligent fruits and vegetables processing system and method
|
WO2020237246A1
|
|
Live attenuated non-transmissible vaccines
|